ENBREL
Biological
PFIZER INTERNATIONAL LLC
Total Payments
$471,530
Transactions
204
Doctors
23
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $3,593 | 2 | 2 |
| 2022 | $1,900 | 1 | 1 |
| 2021 | $4,489 | 2 | 1 |
| 2020 | $39,376 | 23 | 3 |
| 2019 | $34,475 | 20 | 5 |
| 2018 | $180,749 | 77 | 15 |
| 2017 | $206,948 | 79 | 16 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $285,029 | 108 | 60.4% |
| Consulting Fee | $90,473 | 17 | 19.2% |
| Travel and Lodging | $51,692 | 34 | 11.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,410 | 34 | 8.8% |
| Food and Beverage | $2,927 | 11 | 0.6% |
Payments by Type
Research
$285,029
108 transactions
General
$186,501
96 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A MULTICENTER OPENLABEL STUDY OF ETANERCEPT WITHDRAWAL AND RETREATMENT IN SUBJECTS WITH NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WHO ACHIEVED ADEQUATE 24 WEEK RESPONSE | PFIZER INC. | $272,219 | 0 |
| ETANERCEPT CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $12,810 | 3 |
Top Doctors Receiving Payments for ENBREL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Hershey, PA | $272,219 | 96 |
| , M.D | Rheumatology | New York, NY | $35,399 | 13 |
| , MD | Rheumatology | Portland, OR | $27,562 | 17 |
| , MD | Rheumatology | Santa Monica, CA | $24,159 | 10 |
| , MD | Rheumatology | New York, NY | $22,069 | 10 |
| , M.D | Rheumatology | San Francisco, CA | $21,973 | 8 |
| , M.D | Rheumatology | Palo Alto, CA | $12,292 | 3 |
| , M.D | Internal Medicine | Houston, TX | $12,228 | 6 |
| , M.D | Rheumatology | Houston, TX | $6,502 | 2 |
| , MD PHD | Rheumatology | Marlboro, MA | $5,700 | 4 |
| , M.D | Rheumatology | Portola Valley, CA | $5,590 | 4 |
| , M.D | Dermatology | Somers, NY | $4,510 | 3 |
| , M.D., M.M.SC | Dermatology | Boston, MA | $4,510 | 3 |
| , MD | Dermatology | Philadelphia, PA | $3,390 | 6 |
| , MD | Rheumatology | New York, NY | $2,813 | 1 |
| , MD | Rheumatology | Salt Lake City, UT | $2,180 | 3 |
| , MD | Internal Medicine | Salt Lake City, UT | $2,180 | 3 |
| , M.D | Procedural Dermatology | Salt Lake City, UT | $2,180 | 3 |
| , M.D | Dermatology | Salt Lake City, UT | $2,180 | 3 |
| , MD | Pediatric Rheumatology | Cincinnati, OH | $994.65 | 2 |
| , MD | Rheumatology | Seattle, WA | $700.00 | 1 |
| , MD | Internal Medicine | Redwood City, CA | $152.85 | 1 |
| , MD | Rheumatology | Murfreesboro, TN | $30.25 | 1 |
| , M.D | Rheumatology | San Francisco, CA | $18.50 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $412,096
- PFIZER INTERNATIONAL LLC $59,434
Product Information
- Type Biological
- Total Payments $471,530
- Total Doctors 23
- Transactions 204
About ENBREL
ENBREL is a biological associated with $471,530 in payments to 23 healthcare providers, recorded across 204 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INTERNATIONAL LLC.
Payment data is available from 2017 to 2023. In 2023, $3,593 was paid across 2 transactions to 2 doctors.
The most common payment nature for ENBREL is "Unspecified" ($285,029, 60.4% of total).
ENBREL is associated with 2 research studies, including "A MULTICENTER OPENLABEL STUDY OF ETANERCEPT WITHDRAWAL AND RETREATMENT IN SUBJECTS WITH NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WHO ACHIEVED ADEQUATE 24 WEEK RESPONSE" ($272,219).